Harriet Feilotter

8PUBLICATIONS
37CO-AUTHORS
Liquid biopsiesMolecular targetsPredictive and prognostic markersCancer geneticsDigital health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 27, 2026
Evaluating the Utility and Implementation Barriers of a Liquid Biopsy Biomarker Test Early in the Lung Cancer Diagnostic Pathway to Improve Timeliness of Palliative Systemic Therapy.

Adi Kartolo, Laura Semenuk, Harriet Feilotter

|Aug 23, 2024
Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is Transient.

Florence T H Wu, James T Topham, Chris J O'Callaghan

|May 10, 2024
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial.

Jonathan M Loree, Emma Titmuss, James T Topham

|Nov 24, 2023
Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective.

Don Husereau, Yvonne Bombard, Tracy Stockley

|May 15, 2023
Consensus Recommendations to Optimize the Detection and Reporting of NTRK Gene Fusions by RNA-Based Next-Generation Sequencing.

Tracy L Stockley, Bryan Lo, Adrian Box

|Jul 19, 2022
Optimizing the delivery of genetic and advanced diagnostic testing in the province of Ontario: challenges and implications for laboratory technology assessment and management in decentralized healthcare systems.

Don Husereau, Terrence Sullivan, Harriet E Feilotter

Pageof 2

Frequent Collaborators

3 joint publications

Tracy Stockley

2 joint publications

Don Husereau

2 joint publications

Hagen F Kennecke

2 joint publications

Eric X Chen